agilon health (NYSE:AGL - Get Free Report)'s stock had its "hold" rating reiterated by analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.
Several other research analysts have also recently weighed in on the stock. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a report on Monday, November 11th. Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research note on Tuesday, November 12th. William Blair cut agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. Macquarie began coverage on agilon health in a research note on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price on the stock. Finally, Sanford C. Bernstein increased their target price on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research note on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $3.95.
Read Our Latest Stock Report on AGL
agilon health Stock Performance
AGL stock traded down $0.23 during midday trading on Wednesday, reaching $3.12. 6,347,607 shares of the company's stock traded hands, compared to its average volume of 5,615,979. The company has a 50-day moving average price of $2.96 and a two-hundred day moving average price of $3.03. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The firm has a market capitalization of $1.29 billion, a PE ratio of -3.32 and a beta of 0.67.
Insider Transactions at agilon health
In related news, Director Karen Mcloughlin acquired 25,000 shares of the stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now directly owns 73,166 shares of the company's stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the firm's stock in a transaction on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now directly owns 206,133 shares of the company's stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 77,500 shares of company stock worth $169,600. Company insiders own 3.20% of the company's stock.
Institutional Investors Weigh In On agilon health
Institutional investors and hedge funds have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of agilon health during the third quarter valued at approximately $28,000. Oak Thistle LLC purchased a new stake in agilon health in the fourth quarter worth approximately $25,000. Ieq Capital LLC purchased a new stake in agilon health in the fourth quarter worth approximately $26,000. Signaturefd LLC boosted its holdings in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after purchasing an additional 8,467 shares during the last quarter. Finally, Humankind Investments LLC purchased a new stake in agilon health in the fourth quarter worth approximately $30,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.